Clinical trial
Hybrid Sirolimus-eluting Stent With Bioresorbable Polymer Versus Everolimus-eluting Stent With Durable Polymer for Total Coronary Occlusions in Native Coronary Arteries (PRISON-IV)
NCT01516723 is registered in ClinicalTrials.gov with R&D Cardiologie as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Hybrid Sirolimus-eluting Stent With Bioresorbable Polymer Versus Everolimus-eluting Stent With Durable Polymer for Total Coronary Occlusions in Native Coronary Arteries (PRISON-IV)
- Lead sponsor
- R&D Cardiologie
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 29, 2012
- Completion date
- December 31, 2020
- Enrollment
- 330 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.